Barbara Solow
Founder of Concept to Market

With over 25 years of experience in pharmaceutical, biotechnology, and medical device development, Barbara Solow is a recognized leader in non-dilutive funding strategy and healthcare innovation. As the founder of Concept to Market LLC, she has guided organizations ranging from startups to global contractors through product commercialization, regulatory strategy, and public-sector funding, leading programs valued at over $1 billion for U.S. government agencies and helping clients secure more than $3 billion in non-dilutive funding. In this session, Barbara will share how non-dilutive funding can be used to help start and grow a biotech company while minimizing the need for dilutive capital.

Register to attend via Zoom.

The Bench2Market funding series is created to provide commercialization guidance to the university research community.  Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/.